U.S. Healthtech Stock News

In mid-January, AllianceBernstein Holding reported preliminary firmwide net outflows of about US$5.00 billion for the quarter ended December 31, 2025, as Retail withdrawals exceeded inflows from Private Wealth and Institutional clients while analysts reiterated a Hold consensus on the stock. This mix of segment-level fund flow divergence and cautious analyst sentiment highlights how shifts in client behavior can reshape AllianceBernstein’s business profile. We’ll now examine how persistent...

Invesco Mortgage Capital (IVR) just posted its FY 2025 numbers with Q4 revenue of US$56.1 million and basic EPS of US$0.68, giving investors a fresh read on how the portfolio is trading through the mortgage market. Over recent periods, revenue has ranged from US$8.5 million in Q4 2024 to US$57.9 million in Q3 2025, while quarterly EPS has swung between a loss of US$0.40 in Q2 2025 and a gain of US$0.74 in Q3 2025, setting the backdrop for today’s print. With a trailing 12 month net margin of...

Gentex (GNTX) has put up another steady quarter, with Q3 FY 2025 revenue of US$655.2 million and basic EPS of US$0.46, underpinned by net income of US$99.4 million as the latest read on its full year 2025 performance. Over recent periods, revenue has moved from US$541.6 million in Q4 FY 2024 to US$576.8 million in Q1 FY 2025 and then to US$657.9 million in Q2 FY 2025, while basic EPS tracked from US$0.38 to US$0.42 and US$0.43 across those same quarters, giving investors a clear line of sight...

Moog (MOG.A) has opened Q1 2026 earnings season with a fresh set of numbers, coming off a recent quarter where revenue was US$1.0 billion and basic EPS came in at US$2.10, backed by trailing twelve month EPS of US$7.42 on revenue of US$3.9 billion. The company has seen revenue move from US$917.1 million in Q4 2024 to US$1.0 billion in Q4 2025, while quarterly basic EPS stepped up from US$1.39 to US$2.10 over the same stretch, setting the stage for investors to weigh how sustainable that...

United States Antimony (UAMY) is in focus after funding a new commercial scale hydrometallurgical processing facility in Bolivia, paired with exclusive rights to replicate the process in North America and Australia. See our latest analysis for United States Antimony. The funding news lands after a volatile stretch, with a 32.44% 7 day share price decline and an 11.58% 1 day drop, even though the 30 day share price return is 46.02% and the 1 year total shareholder return is very large. This...

Wintrust Financial (WTFC) has drawn fresh attention after reporting higher fourth quarter net interest income and net income year over year, along with a 10% increase to its quarterly common dividend and a separate preferred stock dividend declaration. See our latest analysis for Wintrust Financial. Those stronger fourth quarter earnings and higher dividends come after a steady run in the share price, with a 30 day share price return of 5.47% and a 90 day share price return of 13.42%, while...

Dow Inc. recently reported fourth-quarter 2025 results showing sales of US$9,460 million and a net loss of US$1,543 million, alongside full-year sales of US$39,968 million and a net loss of US$2,623 million. At the same time, the company launched its Transform to Outperform program, including about 4,500 job cuts and heavier use of artificial intelligence and automation to reset its cost base and operations. Next, we’ll examine how Dow’s large-scale Transform to Outperform cost program...

United Rentals (URI) is in focus after its fourth quarter miss on revenue and earnings coincided with a sharp share price drop, along with a new US$5b buyback and a 10% dividend increase. See our latest analysis for United Rentals. The recent fourth quarter miss and guidance update came after a weak stretch for the shares, with a 7 day share price return of a 14.90% decline and a year to date share price return of a 7.46% decline, even though the 5 year total shareholder return of 203.88%...

BMO Capital’s downgrade of First Solar (FSLR), driven by concern over Tesla’s vertically integrated solar ambitions and potential pressure on module pricing, has sharpened investor focus on the company’s competitive position and valuation. See our latest analysis for First Solar. The recent analyst downgrades and concern over Tesla’s plans have coincided with a 30 day share price return of 13.67% decline and a year to date share price return of 17.80% decline. However, the 1 year total...

If you are wondering whether Fabrinet's share price reflects its underlying worth, this article walks through the key numbers and what they might mean for you. Fabrinet's stock recently closed at US$489.44, with returns of 4.8% over 7 days, 7.5% over 30 days, 2.1% year to date, 126.4% over the past year, 267.8% over 3 years and 448.3% over 5 years, providing useful context for any valuation work. Recent coverage around Fabrinet has focused on its role as a tech manufacturing partner. This...

First Reliance Bancshares (FSRL) has put up a busy FY 2025 so far, with Q3 revenue at US$12.1 million, basic EPS of US$0.34 and net income of US$2.7 million setting the tone for its latest update. The company has seen revenue move from US$10.2 million in Q2 2024 to US$13.8 million in Q2 2025, with EPS shifting from US$0.25 to US$0.46 over the same period. This gives you a clearer picture of how the income statement has evolved ahead of the current quarter. With net profit margins over the...

Pinnacle Bank (PBNK) FY 2025 Earnings Snapshot Pinnacle Bank (PBNK) has released its latest FY 2025 figures, reporting third quarter revenue of US$7.4 million and basic EPS of US$0.18. These results set the tone for how the rest of the year is shaping up after earlier quarters of higher earnings. The company has reported quarterly revenue ranging from US$10.1 million in FY 2024 Q2 to US$7.4 million in FY 2025 Q3, while basic EPS has moved between US$0.47 and US$0.18 over the same period. This...

If you are wondering whether Gap's current share price really reflects what the business might be worth, you are not alone. This article walks through that question step by step. Gap shares last closed at US$27.98, with returns of 3.2% over the past week, 9.3% over the past month, 11.1% year to date, 19.9% over the last year and 49.8% over five years, which may have changed how some investors think about its risk and potential. Recent coverage has focused on how Gap is repositioning its...

Rambus recently reported a surge in demand for its semiconductor offerings, as artificial intelligence workloads increase the need for high-performance memory, AI accelerator chips for data centers, and related technologies such as power management, interconnects, security, and clocking. This expansion is underpinned by Rambus’s extensive intellectual property portfolio, reinforcing its role in enabling faster, more efficient memory interfaces and interconnect subsystems for AI-focused...

Central Pacific Financial (CPF) capped FY 2025 with fourth quarter total revenue of US$73.9 million and basic EPS of US$0.86, while trailing twelve month revenue came in at US$277.0 million and EPS at US$2.88. Over the last few quarters, the company has seen revenue move from US$57.6 million in Q4 FY 2024 to US$73.9 million in Q4 FY 2025, with quarterly EPS shifting from US$0.42 to US$0.86 over the same period. With trailing net margin now at 28.0% and profit growth flagged as strong in the...

Dover (DOV) closed out FY 2025 with fourth quarter revenue of US$2,099 million and basic EPS of US$2.02, alongside net income excluding extra items of US$274.8 million. The company has seen quarterly revenue move from US$1,930 million and EPS of US$1.74 in Q4 2024 to US$2,099 million and EPS of US$2.02 in Q4 2025, while trailing 12 month net profit margins have softened from 18.1% to 13.6%. This sets up a results season in which investors are likely to focus squarely on how sustainable those...

In January 2026, Precigen, Inc. reported that an independent expert consensus paper in The Laryngoscope recommended its FDA-approved HPV-specific immunotherapy PAPZIMEOS (zopapogene imadenovec) as the new first-line standard of care for adults with recurrent respiratory papillomatosis, shifting focus from repeated surgery to treating the underlying infection. Because the paper was sponsored by the Recurrent Respiratory Papillomatosis Foundation and shaped with input from patients and...

If you are wondering whether UnitedHealth Group's current share price still reflects its long term potential, you are not alone. This article is designed to help you make sense of the valuation story. The stock has recently faced sharp moves, with a 19.5% decline over the past week and a 45.8% decline over the last year, adding fresh questions about both risk and opportunity at the current price of US$286.93. These moves sit against a backdrop of ongoing attention on large US healthcare...

Wondering if UFP Industries is priced attractively at around US$103 per share, or if the easy money on this stock has already been made. The share price has been relatively active lately, with a 13.4% return over the last 30 days, a 12.0% return year to date, a 9.4% loss over the past year, and a 79.0% gain across five years. Recent coverage has focused on UFP Industries as a key player in the capital goods space, with investors watching how it positions itself across its core product lines...

In January 2026, McCormick reported fourth-quarter 2025 results showing higher sales and earnings from continuing operations, while also updating investors on its completed US$791.87 million share repurchase program and new 2026 earnings guidance that factors in higher tariffs and cost pressures. The company expects a roughly US$50 million tariff impact in 2026 but plans to counter it through productivity gains, alternative sourcing, supply chain initiatives, and pricing actions,...

If you are wondering whether REV Group's current share price reflects its true worth, you are not alone. This article walks through what the market might be pricing in. The stock recently saw a 4.7% decline over the last 7 days, although it is still up 5.1% over 30 days and 2.6% year to date, with a very large 1 year return of 85.1% and an even larger gain over 5 years. Recent attention on REV Group has focused on how the business is positioned within capital goods and specialty vehicles,...

Covenant Logistics Group (CVLG) closed out FY 2025 with fourth quarter revenue of US$295.4 million and a basic EPS loss of US$0.73, capping a trailing twelve month period where revenue was US$1.16 billion and basic EPS was US$0.17. Over that stretch, quarterly revenue moved from US$277.3 million in Q4 2024 to a range of roughly US$269.4 million to US$302.9 million across 2025. Basic EPS shifted from US$0.25 in Q4 2024 to positive readings between US$0.25 and US$0.38 in the first three...

First Internet Bancorp (INBK) closed FY 2025 with fourth quarter revenue of US$29.7 million and EPS of US$0.61, alongside net income of US$5.3 million. This set the tone for how investors interpret the year. Looking back over recent periods, quarterly revenue has ranged from US$19.9 million to US$32.3 million and EPS has moved between a small profit and a very large quarterly loss. Trailing twelve month EPS stands at a loss of US$4.03 on revenue of US$44.2 million. That combination of...

Arthur J. Gallagher (AJG) has wrapped up FY 2025 with fourth quarter revenue of US$3.6b and basic EPS of US$0.58, alongside net income of US$151m. This puts the spotlight on how this year’s figures line up against recent history. The company has seen quarterly revenue move from US$2.5b and basic EPS of US$1.14 in Q4 2024 to US$3.6b and US$0.58 in Q4 2025. Trailing twelve month revenue came in at US$13.9b with basic EPS of US$5.74. With trailing net profit margins at 10.7% versus 13.4% a year...